During the past decade, San Antonio Tumor & Blood Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Antonio Tumor & Blood Clinic" #1 sponsor was "US Oncology Research" with 3 trials, followed by "Agennix" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Antonio Tumor & Blood Clinic" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Chiron Corporation" with 1 trials as a collaborator, "Fred Hutchinson Cancer Center" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "San Antonio Tumor & Blood Clinic" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Hormone Refractory Prostate Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "San Antonio Tumor & Blood Clinic" in a lesser frequency.

Most popular intervention types in "San Antonio Tumor & Blood Clinic" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Aldesleukin" (1 trials), "Anastrozole" (1 trials), "Bevacizumab" (1 trials), "Cetuximab" (1 trials) and "Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Antonio Tumor & Blood Clinic" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "San Antonio Tumor & Blood Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in San Antonio Tumor & Blood Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in San Antonio Tumor & Blood Clinic, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".